These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10960722)

  • 1. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
    MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
    Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
    Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
    Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
    Hanabusa T; Kubo K; Oki C; Nakano Y; Okai K; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of islet amyloid polypeptide after glucagon administration in type 2 diabetic patients and non-diabetic subjects.
    van Jaarsveld BC; Hackeng WH; Lips CJ; Erkelens DW
    Diabet Med; 1993 May; 10(4):327-30. PubMed ID: 8508614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients.
    Sanke T; Hanabusa T; Nakano Y; Oki C; Okai K; Nishimura S; Kondo M; Nanjo K
    Diabetologia; 1991 Feb; 34(2):129-32. PubMed ID: 2065848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet amyloid polypeptide response to maximal hyperglycemia and arginine is altered in impaired glucose tolerance and type 2 diabetes mellitus.
    Guardado-Mendoza R; Chávez AO; Jiménez-Ceja LM; Hansis-Diarte A; DeFronzo RA; Folli F; Tripathy D
    Acta Diabetol; 2017 Jan; 54(1):53-61. PubMed ID: 27624579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.
    Clark PM; Levy JC; Cox L; Burnett M; Turner RC; Hales CN
    Diabetologia; 1992 May; 35(5):469-74. PubMed ID: 1521730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disproportionately elevated proinsulin levels in type 2 diabetic patients treated with sulfonylurea.
    Dworacka M; Abramczyk M; Winiarska H; Kuczynski S; Borowska M; Szczawinska K
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):14-21. PubMed ID: 16425966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Enoki S; Mitsukawa T; Takemura J; Nakazato M; Aburaya J; Toshimori H; Matsukara S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):97-102. PubMed ID: 1541241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of Pro-Islet Amyloid Polypeptide (1-48) in Diabetes and Islet Transplants.
    Courtade JA; Klimek-Abercrombie AM; Chen YC; Patel N; Lu PYT; Speake C; Orban PC; Najafian B; Meneilly G; Greenbaum CJ; Warnock GL; Panagiotopoulos C; Verchere CB
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2595-2603. PubMed ID: 28368485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal proinsulin responses to glucose in mild type II subjects with subnormal insulin response.
    Levy JC; Clark PM; Hales CN; Turner RC
    Diabetes; 1993 Jan; 42(1):162-9. PubMed ID: 8420813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated mathematical model to assess beta-cell activity during the oral glucose test.
    Thomaseth K; Kautzky-Willer A; Ludvik B; Prager R; Pacini G
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E522-31. PubMed ID: 8638701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased proinsulin levels as an early indicator of B-cell dysfunction in non-diabetic twins of type 1 (insulin-dependent) diabetic patients.
    Heaton DA; Millward BA; Gray IP; Tun Y; Hales CN; Pyke DA; Leslie RD
    Diabetologia; 1988 Mar; 31(3):182-4. PubMed ID: 3286344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men.
    Kahn SE; Leonetti DL; Prigeon RL; Boyko EJ; Bergstom RW; Fujimoto WY
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S63-6. PubMed ID: 8894485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients.
    Narita R; Toshimori H; Nakazato M; Kuribayashi T; Toshimori T; Kawabata K; Takahashi K; Masukura S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):3-14. PubMed ID: 1541232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes.
    Clark A; Matthews DR; Naylor BA; Wells CA; Hosker JP; Turner RC
    Diabetes Res; 1987 Feb; 4(2):51-5. PubMed ID: 2884060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No correlation between insulin and islet amyloid polypeptide after stimulation with glucagon-like peptide-1 in type 2 diabetes.
    Ahrén B; Gutniak M
    Eur J Endocrinol; 1997 Dec; 137(6):643-9. PubMed ID: 9437230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relation between fasting plasma glucose concentrations and insulin resistance].
    Li L; Wang GX; Li P; Shang XJ; Liu C; Wang YJ; Yue GY
    Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):755-8. PubMed ID: 16255885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of insulin treatment on circulating islet amyloid polypeptide in patients with NIDDM.
    Lindström T; Leckström A; Westermark P; Arnqvist HJ
    Diabet Med; 1997 Jun; 14(6):472-6. PubMed ID: 9212313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.